Targeting diabetes prevention to more disadvantaged groups improves cost-effectiveness: Implications of inequality in type 2 diabetes from theoretical interventions.
Jedidiah I MortonClara MarquinaDianna J MaglianoJonathan E ShawZanfina AdemiPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
Policies targeted at more disadvantaged populations will likely be cost-effective at higher costs and lower efficacy compared to untargeted policies. Future health economic models should incorporate measures of socioeconomic disadvantage to improve targeting of interventions.
Keyphrases
- type diabetes
- public health
- cancer therapy
- glycemic control
- physical activity
- cardiovascular disease
- healthcare
- mental health
- mass spectrometry
- drug delivery
- insulin resistance
- health information
- liquid chromatography
- adipose tissue
- gas chromatography mass spectrometry
- skeletal muscle
- high resolution
- weight loss
- health promotion
- high resolution mass spectrometry
- tandem mass spectrometry